Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Comment by mcarter4on Dec 10, 2003 4:08pm

318 Views

Post# 6765543

RE: 66k trade

Do you think BT read the Toronto Star article on Bellini, and rethought the appropriateness of owning shares in his own companY?? You know here's a thought on BT, why does he invest in Belllini's companies but not his own (I'm assuming he has an investment in NRM based on his comments in the Star)?? Funny he admires CEO attributes that he has yet to show he possesses?? Do you think he sold his NRM holdings before he sold out of ONC?? OR was he selling ONC to buy more NRM??

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario